Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fusion Antibodies
Belfast, Northern Ireland, United Kingdomfusionantibodies.com ↗
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
Fusion Antibodies provides end-to-end antibody discovery, engineering, and cell line development services to pharmaceutical and biotech companies. Its technologies have contributed to multiple client programs entering clinical trials, though it does not report its own clinical results.
- Therapeutic areas
- Infectious DiseasesOncologyOther
- Modalities
- Monoclonal antibodyRecombinant proteinAntibody-drug conjugateBiologic
- Industry
- Drug Discovery Services
02
Partnerships
National Cancer Institute – collaboration using OptiMAL platform for novel antibody discovery against NCI-selected targets
Beyond the preview
Go deeper on Fusion Antibodies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fusion Antibodies.